Molecular tumor boards improve patient outcomes in advanced cancer patients by bringing together oncologists, pathologists, radiologists, clinical geneticists, scientific researchers, and bioinformatics experts to discuss the intricacies of tumor genetics and tailor personalized treatment plans for those who have exhausted standard therapies.